Literature DB >> 25064216

Synthesis and anti-cancer activity of naturally occurring 2,5-diketopiperazines.

Adriano Mollica1, Roberto Costante2, Serena Fiorito2, Salvatore Genovese2, Azzurra Stefanucci3, Veronique Mathieu4, Robert Kiss4, Francesco Epifano2.   

Abstract

Three naturally occurring oxyprenylated diketopiperazines were synthesized and preliminarily tested as growth inhibitory agents in vitro against various cancer cell lines. The compounds were tested on six human cancer cell lines with different sensitivity to proapoptotic stimuli using the MTT colorimetric assay. The data revealed that of the chemicals under study only deoxymicelianamide (11) displayed the highest activity, recording mean IC50 growth inhibitory values ranging from 2 to 23 μM. A comparative study with the non-geranylated saturated derivative of (11) revealed the importance of the presence of the geranyloxy side chain and the exocyclic 2,5-DPK double bond moiety for the observed activity.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Diketopiperazines; In vitro growth inhibition; Oxyprenylated secondary metabolites

Mesh:

Substances:

Year:  2014        PMID: 25064216     DOI: 10.1016/j.fitote.2014.07.010

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  3 in total

1.  Neuroprotective Effect of Cyclo-(L-Pro-L-Phe) Isolated from the Jellyfish-Derived Fungus Aspergillus flavus.

Authors:  Dan-Dan Li; Ying Wang; Eun La Kim; Jongki Hong; Jee H Jung
Journal:  Mar Drugs       Date:  2021-07-26       Impact factor: 6.085

2.  Synthesis of monoalkylidene diketopiperazines and application to the synthesis of barettin.

Authors:  Elizabeth W Kelley; Skylar G Norman; Jonathan R Scheerer
Journal:  Org Biomol Chem       Date:  2017-10-18       Impact factor: 3.876

3.  Microindolinone A, a Novel 4,5,6,7-Tetrahydroindole, from the Deep-Sea-Derived Actinomycete Microbacterium sp. MCCC 1A11207.

Authors:  Siwen Niu; Ting-Ting Zhou; Chun-Lan Xie; Gai-Yun Zhang; Xian-Wen Yang
Journal:  Mar Drugs       Date:  2017-07-19       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.